![]() |
市場調查報告書
商品編碼
1820440
2025 年至 2033 年婦科設備市場規模、佔有率、趨勢及預測(依產品、最終用途及地區)Gynecology Devices Market Size, Share, Trends and Forecast by Product, End Use and Region, 2025-2033 |
2024年,全球婦科器材市場規模達136.4億美元。預計到2033年,該市場規模將達到241.9億美元,2025年至2033年的複合年成長率為6.25%。女性健康意識的不斷增強以及專科醫療服務的普及,促使更多女性尋求及時的醫療介入。透過診斷中心提供醫療服務的分散化,進一步提升了婦科器械市場佔有率。
目前,子宮內膜異位症和子宮頸癌等婦科疾病發生率的不斷上升推動了市場的發展。女性健康意識的提高和預防性篩檢的普及,進一步推動了先進工具的早期發現和治療。包括機器人輔助手術、先進影像技術和能量驅動設備在內的技術創新,正在提高診斷的準確性、安全性和病患治療效果。此外,醫療保健基礎設施的不斷擴張(尤其是在發展中地區),加上醫療解決方案支出的增加,使得婦科設備更加容易獲得。人口老化和生活方式相關的健康問題也為婦科設備市場帶來了良好的前景。
由於多種因素,美國已成為婦科設備市場的主要地區。強大的醫療保健生態系統和對先進女性健康解決方案的日益重視正在推動市場成長。婦科疾病的高發病率,加上人們對預防保健和早期診斷的認知的提高,正在催化對創新設備的強勁需求。手術機器人、微創 (MI) 診斷工具和基於能量的治療設備等技術進步被醫院和專科診所廣泛採用,確保改善患者護理。根據IMARC Group的數據,美國手術機器人市場規模在 2024 年達到 215 億美元。此外,強大的保險覆蓋範圍正在提高婦科設備的可及性和可負擔性。
婦科疾病發生率不斷上升
婦科疾病發生率的上升推動了婦科設備市場的成長。子宮肌瘤、子宮內膜異位症、卵巢囊腫、不孕症和子宮頸癌等疾病在各個年齡層的女性中都有報導,這些疾病通常與生活方式的改變、延遲懷孕和荷爾蒙失調有關。根據美國癌症協會對子宮頸癌的估計,到 2025 年,美國將診斷出 13,360 例新的侵襲性子宮頸癌病例。這種激增催生了對能夠早期發現、準確診斷和有效治療的設備的需求。醫院和診所正在採用先進的影像系統、手術設備和監測工具來滿足這一需求。此外,人們對女性健康的認知不斷提高以及專科護理的普及,鼓勵更多女性及時尋求醫療干預。
診斷中心的建立日益增多
診斷中心的不斷增多,改善了專科醫療保健和早期檢測服務的可近性。隨著女性健康和預防保健意識的不斷增強,診斷中心在城市和半城市地區迅速擴張,提供生殖健康、生育評估和癌症篩檢等專業服務。這些機構擴大配備了先進的婦科設備,例如超音波系統、子宮腔鏡和MI診斷工具,以提供準確且高效的結果,增強使用者的信賴度。例如,根據ekincare的報告,到2025年7月,82%的印度人選擇在診斷中心而非醫院進行預防性身體檢查。透過診斷中心實現醫療保健服務的分散化,減輕了醫院的負擔,並使基本服務更貼近患者。此外,私人醫療機構的興起以及對診斷基礎設施的投資,進一步加速了現代婦科設備的普及。
MI 手術的上升趨勢
越來越多採用 MI 手術是婦科設備市場的主要趨勢之一。根據IMARC Group的數據,歐洲 MI 手術市場規模在 2024 年達到 63 億美元,預計到 2033 年將以 3.53% 的複合年成長率成長至 88 億美元。女性越來越青睞腹腔鏡和子宮鏡等 MI 技術,因為與傳統的開放性手術相比,這些技術可以減少手術創傷、最大限度地減少疤痕、縮短住院時間並確保更快的康復。這種日益成長的偏好導致對先進 MI 婦科設備的需求激增,包括內視鏡、基於能量的儀器和機器人輔助系統。醫生也青睞這些技術,因為它們具有更高的精確度、更低的併發症發生率和更好的患者治療效果。訓練有素的專家越來越多,而技術進步使 MI 設備更加可靠和高效,進一步推動了這些技術的採用。
The global gynecology devices market size was valued at USD 13.64 Billion in 2024. The market is projected to reach USD 24.19 Billion by 2033, exhibiting a CAGR of 6.25% from 2025-2033. The growing awareness about women's health and the availability of specialized care are encouraging more women to seek timely medical intervention. The decentralization of healthcare delivery through diagnostic centers is further propelling the gynecology devices market share.
At present, the market is driven by the growing incidence of gynecological disorders, such as endometriosis and cervical cancer. Increasing awareness about women's health and preventive screening is further promoting the adoption of advanced tools for early detection and treatment. Technological innovations, including robotic-assisted surgeries, advanced imaging, and energy-based devices, are improving accuracy, safety, and patient outcomes. Additionally, expanding healthcare infrastructure, especially in developing regions, coupled with increased spending on medical solutions, is making gynecology devices more accessible. Moreover, aging population and lifestyle-related health concerns are offering a favorable gynecology devices market outlook.
The United States has emerged as a major region in the gynecology devices market owing to many factors. The presence of a strong healthcare ecosystem and rising emphasis on advanced women's health solutions are fueling the market growth. High prevalence of gynecological disorders, coupled with increased awareness about preventive care and early diagnosis, is catalyzing robust demand for innovative devices. Technological advancements, such as surgical robots, minimally invasive (MI) diagnostic tools, and energy-based treatment devices, are widely adopted across hospitals and specialty clinics, ensuring improved patient care. As per the IMARC Group, the United States surgical robots market size reached USD 21.5 Billion in 2024. Additionally, strong insurance coverage is enhancing the accessibility and affordability of gynecology devices.
Increasing incidence of gynecological disorders
Rising incidence of gynecological disorders is impelling the gynecology devices market growth. Conditions, such as uterine fibroids, endometriosis, ovarian cysts, infertility, and cervical cancer, are being reported among women of various age groups, often linked to lifestyle changes, delayed pregnancies, and hormonal imbalances. According to the American Cancer Society's estimates for cervical cancer, in 2025, 13,360 new cases of invasive cervical cancer are set to be diagnosed in the United States. This surge is creating the need for devices that enable early detection, accurate diagnosis, and effective treatment. Hospitals and clinics are adopting advanced imaging systems, surgical devices, and monitoring tools to meet this demand. Moreover, the growing awareness about women's health and the availability of specialized care are encouraging more women to seek timely medical intervention.
Growing establishment of diagnostic centers
Rising establishment of diagnostic centers is improving access to specialized healthcare and early detection services. With the growing consciousness about women's health and preventive care, diagnostic centers are expanding rapidly in urban and semi-urban areas, offering dedicated services for reproductive health, fertility assessments, and cancer screening. These facilities are increasingly equipped with advanced gynecology devices, such as ultrasound systems, hysteroscopes, and MI diagnostic tools, to provide accurate and efficient results, enhancing user reliance. For instance, as per the ekincare report, by July 2025, 82% Indians opted for diagnostic centers over hospitals for preventive check-ups. The decentralization of healthcare delivery through diagnostic centers reduces the burden on hospitals and brings essential services closer to patients. Additionally, the rise of private healthcare providers and investments in diagnostic infrastructure is further accelerating the adoption of modern gynecology equipment.
Rising trend of MI procedures
Increasing adoption of MI procedures is among the major gynecology devices market trends. As per the IMARC Group, the Europe MI surgery market size reached USD 6.3 Billion in 2024 and is set to grow at a CAGR of 3.53% to reach USD 8.8 Billion by 2033. Women increasingly prefer MI techniques, such as laparoscopy and hysteroscopy, because they reduce surgical trauma, minimize scarring, shorten hospital stays, and ensure faster recovery compared to traditional open surgeries. This growing preference has led to a surge in the demand for advanced MI gynecology devices, including endoscopes, energy-based instruments, and robotic-assisted systems. Physicians also favor these technologies due to improved precision, lower complication rates, and better patient outcomes. The expanding availability of trained specialists and technological advancements that make MI devices more reliable and efficient are further fueling the adoption.
Surgical devices {gynecological endoscopy devices (hysteroscope, colposcope, resectoscope, laparoscope, and endoscopic imaging systems), endometrial ablation devices (hydrothermal ablation devices, radiofrequency ablation devices, balloon ablation devices, and others), fluid management systems, and female sterilization/contraceptive devices (permanent birth control, intra uterine devices (IUD), intravaginal rings, and subdermal contraceptive implants) held XX% of the market share in 2024. They are essential tools in addressing a wide range of gynecological ailments that require operative intervention. Conditions, such as fibroids, endometriosis, ovarian cysts, and cancers, often necessitate surgical treatments, making surgical devices highly indispensable. With the rising adoption of MI techniques, advanced surgical instruments like laparoscopes, hysteroscopes, and robotic-assisted tools are in high demand, offering greater precision, reduced recovery times, and improved patient outcomes. The growing number of gynecological surgeries, including hysterectomies, myomectomies, and fertility-related procedures, is further promoting their usage. Continuous innovations in surgical devices, including the integration of imaging and energy-based technologies, have expanded treatment possibilities and improved safety. As per the gynecology devices market forecast, with increasing patient preferences for advanced and less invasive solutions, surgical devices will continue to hold dominance.
Hospitals and clinics account for XX% of the market share. They serve as the primary points of care for women seeking diagnosis, treatment, and surgical interventions for gynecological conditions. These facilities are well-equipped with advanced infrastructure, skilled healthcare professionals, and comprehensive services, making them the preferred choice for patients requiring both routine and complex procedures. Hospitals and clinics handle a high volume of patients, enabling them to invest in and adopt the latest technologies, such as MI and robotic-assisted surgical systems. Their ability to provide emergency care, fertility treatments, and cancer management also strengthens their dominance. Additionally, strong reimbursement support, integration of multidisciplinary care teams, and widespread accessibility in both urban and semi-urban regions are contributing to their leadership. Increasing incidence of gynecological diseases, coupled with the high demand for advanced procedures performed in safe and controlled environments, ensures hospitals and clinics maintain the largest share in the market.
North America, accounting for a share of XX%, enjoys the leading position in the market. The region is noted for its modern medical facilities, significant healthcare investments, and a strong focus on women's health. In September 2024, the US Department of Health and Human Services (HHS), via the Centers for Medicare & Medicaid Services (CMS), introduced a groundbreaking grant initiative to allocate nearly USD 9 Million aimed at enhancing women's health insurance and access to vital health services. The region has a high incidence of gynecological conditions, such as uterine fibroids, endometriosis, and cervical cancer, driving strong demand for advanced diagnostic and treatment devices. Widespread adoption of MI and robotic-assisted surgical procedures is also a key driver, supported by the presence of leading medical device manufacturers who are constantly innovating and expanding their offerings. Favorable reimbursement policies, extensive insurance coverage, and government-backed initiatives to improve women's health are further strengthening the market growth.
United States Gynecology Devices Market Analysis
The United States is witnessing increased adoption of gynecology devices due to the growing expenditure on healthcare infrastructure, leading to advanced facilities equipped with modern diagnostic and surgical tools. For instance, in the US, investment in the medical device sector surged at the start of 2025, reaching USD 2.6 Billion in funding during the first quarter through 132 deals, marking the highest quarterly total in three years. Enhanced funding in public and private healthcare systems has enabled hospitals and clinics to procure technologically sophisticated gynecology devices for procedures, such as hysteroscopy, colposcopy, and diagnostic imaging. These investments are also facilitating training programs for medical staff, ensuring efficient utilization of devices. Rising awareness about women's health, coupled with increasing healthcare access and patient preference for MI treatments, is also contributing to the high demand. Additionally, the integration of electronic health records (EHRs) and telehealth platforms is supporting the deployment of gynecology devices across both urban and rural facilities, reinforcing the impact of healthcare infrastructure development on overall market expansion in the country.
Europe Gynecology Devices Market Analysis
Europe is seeing higher usage of gynecology devices due to increasing cervical cancer cases, leading to heightened focus on early detection, diagnosis, and treatment. For instance, in 2024, approximately 33,000 cervical cancer cases occurred in the EU, leading to an estimated 15,000 fatalities. The rise in cervical cancer prevalence has driven the demand for colposcopes, biopsy devices, and Human Papillomavirus (HPV) screening instruments. Healthcare providers are emphasizing preventive care programs and public awareness campaigns to encourage routine gynecological check-ups, where gynecology devices play a central role. With cervical cancer being one of the most prevalent cancers among women, there is a growing emphasis on screening programs and vaccination drives, which require diagnostic tools. Hospitals and clinics across the region are upgrading their gynecology departments with better technologies to manage this rising burden.
Asia-Pacific Gynecology Devices Market Analysis
The Asia-Pacific region is experiencing strong growth in the adoption of gynecology devices due to the rapid rise of diagnostic centers across urban and semi-urban areas. For instance, in 2025, there were 300,000 diagnostic labs spread across India. As more diagnostic centers are emerging, the demand for devices, such as ultrasound systems, endoscopic instruments, and cervical screening tools, has increased. The expanding network of diagnostic centers enables early detection and monitoring of gynecological conditions, encouraging continuous investments in advanced equipment. This expansion is also supported by the growing public awareness about reproductive health and the increasing affordability of diagnostics. Many diagnostic centers are partnering with technology firms to integrate digital imaging and automation, improving diagnostic accuracy. High patient volume handled by these centers is further promoting the use of efficient and user-friendly gynecology devices.
Latin America Gynecology Devices Market Analysis
Latin America is experiencing an uptick in the employment of gynecology devices owing to the growing expansion of healthcare facilities. For instance, government funding for Brazil's Unified Health System was set to rise by 6.2% in 2025. Improved medical infrastructure and rising involvement of private healthcare providers are enabling broader access to modern gynecology tools. The broadening of healthcare facilities is enhancing diagnostic and treatment capacity for women's health issues, especially in urban areas.
Middle East and Africa Gynecology Devices Market Analysis
The Middle East and Africa region is showing steady gynecology device adoption supported by the expansion of hospitals and clinical facilities. For instance, in early 2025, the UAE hosted over 150 hospitals and had more than 5,000 healthcare facilities. Infrastructure development is strengthening service availability, while new hospitals and clinics are investing in modern gynecological tools. The broadening of such healthcare institutions ensures improved access to screenings, diagnostics, and treatment, thereby catalyzing the demand for gynecology devices across the region.
Key players are continuously innovating, expanding product portfolios, and ensuring wider accessibility of advanced solutions. Through heavy investments in research and development (R&D) activities, they are introducing cutting-edge technologies, such as robotic-assisted surgical systems, MI diagnostic tools, and energy-based treatment devices that improve accuracy and patient outcomes. Strategic collaborations with hospitals, fertility centers, and research institutions aid in accelerating clinical adoption and broadening applications of these devices. Moreover, key players focus on regulatory approvals and compliance to ensure safety and reliability, boosting trust among healthcare professionals. They are also expanding into emerging markets through distribution partnerships and localized manufacturing, making devices more affordable and accessible. Marketing initiatives, physician training programs, and patient awareness campaigns are further enhancing adoption. For instance, in January 2025, at SMFM 2025 in Denver, Samsung Medison unveiled the AI-driven Z20 gynecology device, presenting cutting-edge Ob-Gyn ultrasound technologies that tackled diagnostic issues in women's health through improved imaging and a clinician-centric design. The Z20 represented a significant advancement in gynecological devices with artificial intelligence (AI) integration, specifically designed for high-BMI patients and varying operator skills.